Skip to main content
Clinical Trials/EUCTR2008-005987-15-NL
EUCTR2008-005987-15-NL
Active, not recruiting
Not Applicable

Preventing preterm birth: Costs and effects of screening of healthy women with a singleton pregnancy for a short cervical length. - The Triple P study

AMC Amsterdam0 sitesOctober 30, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
AMC Amsterdam
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2008
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
AMC Amsterdam

Eligibility Criteria

Inclusion Criteria

  • \-\- Capacitated women
  • \-\- \= 18 years old
  • \-\- Singleton healthy pregnancy
  • \-\- Two times a cervical length \= 25 mm: a cervical length \= 25 mm at 16\-20 weeks gestation, and a confirmation of this result with a repeat measurement of the cervical length at 20\-22 weeks gestation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Women with a pregnancy with major foetal abnormalities, painful regular uterine contractions, a history of ruptured membranes or a cervical cerclage will be excluded. In addition, women with a previous preterm birth are excluded as well.

Outcomes

Primary Outcomes

Not specified

Similar Trials